CELLA, CHIARA ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 1.001
EU - Europa 177
AS - Asia 48
OC - Oceania 2
SA - Sud America 1
Totale 1.229
Nazione #
US - Stati Uniti d'America 997
UA - Ucraina 49
HK - Hong Kong 28
IE - Irlanda 27
DE - Germania 25
FI - Finlandia 25
CN - Cina 18
GB - Regno Unito 18
IT - Italia 15
BE - Belgio 10
CA - Canada 4
AU - Australia 2
JP - Giappone 2
RU - Federazione Russa 2
BR - Brasile 1
ES - Italia 1
FR - Francia 1
LU - Lussemburgo 1
MD - Moldavia 1
RS - Serbia 1
SE - Svezia 1
Totale 1.229
Città #
Fairfield 170
Chandler 131
Woodbridge 83
Seattle 75
Wilmington 69
Houston 67
Ashburn 66
Princeton 54
Cambridge 46
Jacksonville 43
Hong Kong 28
Dublin 27
Helsinki 25
Ann Arbor 16
Shanghai 11
Brussels 10
New York 10
San Diego 9
Des Moines 7
London 6
San Francisco 5
Beijing 3
Toronto 3
Islington 2
Kilburn 2
Redwood City 2
Sabbio Chiese 2
Belgrade 1
Boardman 1
Brescia 1
Catania 1
Changchun 1
Chisinau 1
Chiswick 1
Edinburgh 1
Jinan 1
Leawood 1
Leipzig 1
Luxembourg 1
Markham 1
Melbourne 1
New Bedfont 1
Norwalk 1
Prescot 1
Shenyang 1
Southwark 1
Sydney 1
Tianjin 1
Tokyo 1
Wandsworth 1
Totale 995
Nome #
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis 92
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumors 72
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis 64
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion of etiopathogenesis and diagnostic tools 62
Treatments for colorectal liver metastases: A new focus on a familiar concept 55
Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: from bench to bedside 53
Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients 53
The role of multimodal treatment in patients with advanced lung neuroendocrine tumors 52
Adjuvant Treatment for Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy: When, and for Whom? 49
Bevacizumab maintenance in metastatic colorectal cancer: How long? 48
Digital Ischemia in Patients with Solid Tumors: a Case Report and Review of the Literature 48
Primary prevention of cancer-related thrombosis: special focus on ambulatory patients 44
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis 44
Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors 41
Successful palliative approach with high-intensity focused ultrasound in a patient with metastatic anaplastic pancreatic carcinoma: a case report 40
Should cT2N0M0 be managed as a localized or locally advanced esophageal carcinoma? 40
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 40
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience 40
Basaloid squamous cell carcinoma: a rare tumor at the esophagogastric junction and an unexpected durable complete response to FOLFOX-4 39
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors 39
HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target? 38
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectives 37
The Italian Rare Pancreatic Exocrine Cancer Initiative 35
Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms 35
High-risk human papillomavirus in anal squamous cell carcinoma: A 'conservative' leading role 34
Systemic therapy beyond first-line in advanced gastric cancer: An overview of the main randomized clinical trials 30
Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor 28
The pandemic within the pandemic: the surge of neuropsychological disorders in Italian children during the COVID-19 era 5
Cabozantinib in neuroendocrine tumours: tackling drug activity and resistance mechanisms 3
Totale 1.260
Categoria #
all - tutte 8.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 1 3 6 5
2019/202031 4 1 2 3 2 3 3 3 2 4 2 2
2020/2021608 0 2 0 56 244 17 39 56 57 76 27 34
2021/2022178 0 42 3 11 1 9 15 21 13 6 7 50
2022/2023300 27 0 3 50 14 83 4 33 56 0 13 17
2023/2024122 21 3 11 29 1 10 3 10 34 0 0 0
Totale 1.260